In line with the above findings, our data showed suppression of AKR1B10 by OA could also rescue the tumor promoting effect of CBX7 knockdown on cell proliferation, invasion, and stemness, implying OA would be a promising pharmacological inhibition for targeting AKR1B10 in UBC. This evidence concerns the gene AKR1B10 and neoplasm.